arrow_back View All Dates
-
1:00pm • Oral Session 14:PHENOMENOLOGY: IDENTIFICATION IN EARLY PSYCHOSIS
-
1:05pm • Oral 14, Talk 1. "Risk or Typical Development? The Impact of Race, Neighborhood Crime, and Age on Accurate Identification of Ultra High Risk States"
-
1:15pm • Oral 14, Talk 2. "From Clinical Staging and Profiling to Prevention in Mental Health Care"
-
1:25pm • Oral 14, Talk 3. "Reducing the Stigmatizing Risks of the ‘At-risk’ State: Promising Pilot Results from Two Experimental Vignette Studies of the Effects of Labeling versus Symptoms Severity"
-
1:35pm • Oral 14, Talk 4. "The Early Psychosis Screener (EPS-SVM): a Practical Self-Report Tool using Machine Learning to Predict Psychosis"
-
1:45pm • Oral 14, Talk 5. "Clinical prediction besides transition to psychosis in the Ultra-High Risk for psychosis population"
-
1:55pm • Oral 14, Talk 6. "Complement Pathway Changes at Age 11 Are Associated with Psychotic Experiences at Age 18 and with Persistence of Psychotic Experiences from Age 11 to Age 18; Evidence from a Nested Case Control Study of the ALSPAC Birth Cohort."
-
2:05pm • Oral 14, Talk 7. "Basic Self-disturbance in Adolescence and Schizophrenia-spectrum Disorders in Young Adulthood: A 7-year Follow-up Study among Treatment-seeking Adolescents."
-
2:15pm • Oral 14, Talk 8. "The Organization of Symptoms in Early Psychosis: A Systems Approach to Phenomenology"
-
2:25pm • Oral 14: Q&A
-
2:45pm • Oral Session 17: SUBSTANCE USE AND OTHER COMORBIDITIES
-
2:50pm • Oral 17, Talk 1. "Co-occurrence of autism and psychosis traits in young adolescents: impact on theory of mind"
-
3:00pm • Oral 17, Talk 2. "The Prevalence of Attention Deficit Hyperactivity Disorder Symptoms in a Cohort of Patients with Schizophrenia, and the Impact on Their Executive Functions"
-
3:10pm • Oral 17, Talk 3. "Autism and Psychosis; Implications for clinical symptoms, quality of life and functioning"
-
3:20pm • Oral 17, Talk 4. "Suicidal behaviour in early psychosis. The role of insight"
-
3:30pm • Oral 17, Talk 5. "Illicit substance use in first episode psychosis (FEP): a natural language processing (NLP) electronic health record study
-
3:40pm • Oral 17, Talk 6. CANCELLED
-
3:50pm • Oral 17, Talk 7. "Cannabis and other substance use predicts conversion from schizotypal disorder to schizophrenia"
-
4:00pm • Oral 17, Talk 8. "Back to Reality Series Video Games: Translating Research Knowledge about Marijuana and Psychosis for Youth"
-
4:10pm • Oral 17: Q&A
-
1:00pm • Oral Session 15: RISK FOR PSYCHOSIS AND OTHER DISORDERS
-
1:05pm • Oral 15, Talk 1. "Migration History and Risk of Psychosis in the EU-GEI Study"
-
1:15pm • Oral 15, Talk 2. "Elevated exposure to air pollution is associated with the emergence of psychotic experiences during adolescence"
-
1:25pm • Oral 15, Talk 3. "Psychotic Experiences are Associated with Suicidal Ideation and Non-Suicidal Self-Injury in Pre-adolescence"
-
1:35pm • Oral 15, Talk 4. "Psychosis Risk Syndrome in students of Junior Middle School in Zhongshan, china: prevalence and characteristics"
-
1:45pm • Oral 15, Talk 5. "Psychopathology in 7-year-old children with familial high risk of schizophrenia or bipolar disorder – The Danish High Risk and Resilience Study – VIA 7; a population-based cohort study"
-
1:55pm • Oral 15, Talk 6. "Quality of life and self-esteem in 7-year-old children with familial high risk of schizophrenia or bipolar disorder – Correlations with psychopathology and level of functioning in: The Danish High Risk and Resilience Study – VIA7; a popu
-
2:05pm • Oral 15, Talk 7. "Developmental trajectories of childhood symptoms of hyperactivity/inattention and suicidal behavior during adolescence"
-
2:15pm • Oral 15, Talk 8. "Somatic diseases and mortality among offspring of parents with severe mental illness – a nationwide register-based cohort study in 2,000,669 individuals."
-
2:25pm • Oral 15: Q&A
-
2:45pm • Oral Session 18: STRESS AND COPING
-
2:50pm • Oral 18, Talk 1. "The mental health of trans young people aged 14-25 years in Australia: findings from Trans Pathways"
-
3:00pm • Oral 18, Talk 2. "Born Out of Fear: A Grounded Theory Study of the Stigma of Bipolar Disorder for New Mothers"
-
3:10pm • Oral 18, Talk 3. "Affective lability and polygenic risk in bipolar disorder"
-
3:20pm • Oral 18, Talk 4. "Cortisol reactivity to daily-life stressors in psychosis"
-
3:30pm • Oral 18, Talk 5. "Detecting distress in adolescents and young adults using big data analysis of social media"
-
3:40pm • Oral 18, Talk 6. "A structural equation modeling meta-analysis of coping, locus of control, self-efficacy and mental health"
-
3:50pm • Oral 18, Talk 7. "Direct and indirect effects of coping, self-efficacy and control beliefs to promote mental health and quality of life in a general population sample"
-
4:00pm • Oral 18, Talk 8. " The Association between War-related Stress, PTSD Symptoms, and Sub-clinical Psychosis: A Cross-cultural Population-based Study among Palestinian and Israeli Youth."
-
4:10pm • Oral 18: Q&A
-
1:00pm • Oral Session 13: TREATMENT WITH ANTIPSYCHOTICS
-
1:05pm • Oral 13, Talk 1. "The Impact of Clozapine Use in Early-Intervention: a Retrospective Chart Audit"
-
1:15pm • Oral 13, Talk 2. "Long-acting Aripiprazole in First-Episode Psychosis: does one size fit all?"
-
1:25pm • Oral 13, Talk 3. "Predictors of outcomes following discontinuation of antipsychotic medication after a first episode of psychosis – findings from a systematic review and cohort study"
-
1:35pm • Oral 13, Talk 4. "Impact of early use of long-acting injectable antipsychotics on psychotic relapse and re-hospitalization in first-episode psychosis"
-
1:45pm • Oral 13, Talk 5. "Predictors of 'all cause discontinuation' of initial oral antipsychotic medication in first episode psychosis"
-
1:55pm • Oral 13, Talk 6. "Cognitive functioning following discontinuation of antipsychotic medication. A sub-group analysis from the OPUS II trial."
-
2:05pm • Oral 13, Talk 7. "Citalopram in first episode psychosis: the DECIFER Trial"
-
2:15pm • Oral 13, Talk 8. "Early non-response to antipsychotic medication in adolescents with first-episode psychosis is a reliable predictor of ultimate non-response and non-remission: Results from the 12-week TEA trial"
-
2:25pm • Oral 13: Q&A
-
2:45pm • Oral Session 16: TREATMENT TARGETS
-
2:50pm • Oral 16, Talk 1. "Longitudinal Trajectory of Early Functional Recovery in Patients with First Episode Psychosis"
-
3:00pm • Oral 16, Talk 2. "Identifying targets for intervention in suicidal behaviour using the integrated motivational-volitional model"
-
3:10pm • Oral 16, Talk 3. "Does Mental Health Treatment Help the Formation of Social Resilience to Emerging General Distress in Young People?"
-
3:20pm • Oral 16, Talk 4. "Risk of homelessness and housing instability among first-time mental health service users"
-
3:30pm • Oral 16, Talk 5. "Effectiveness of Providing University Students with a Mindfulness-Based Intervention to Increase Resilience to Stress: A Pragmatic Randomised Controlled Trial:
-
3:40pm • Oral 16, Talk 6. "Service Users Experiences of Peer-Supported Open Dialogue Informed Network Meetings"
-
3:50pm • Oral 16, Talk 7. "The Social Inclusion of Young People with Serious Mental Illness: A Narrative Review of the Literature and Suggested Future Directions"
-
4:00pm • Oral 16, Talk 8. "“A Sense of Hope”: A qualitative exploration of the family members experience of peer support in an Early Intervention program"
-
4:10pm • Oral 16: Q&A
